Institutional Investor’s Pro-Prestige Brands International LLC (NYSE:PBH) Sentiment In Q2 2018

Prestige Consumer Healthcare Inc. (NYSE:PBH) Logo

Sentiment for Prestige Brands International LLC (NYSE:PBH)

Prestige Brands International LLC (NYSE:PBH) institutional sentiment increased to 1.72 in Q2 2018. Its up 0.47, from 1.25 in 2018Q1. The ratio increased, as 129 investment managers increased or opened new equity positions, while 75 sold and decreased positions in Prestige Brands International LLC. The investment managers in our partner’s database now possess: 61.54 million shares, down from 62.22 million shares in 2018Q1. Also, the number of investment managers holding Prestige Brands International LLC in their top 10 equity positions increased from 1 to 2 for an increase of 1. Sold All: 28 Reduced: 47 Increased: 89 New Position: 40.

Prestige Brands Holdings, Inc., through its subsidiaries, markets, sells, makes, and distributes over-the-counter healthcare and household cleaning products in North America, Australia, and internationally. The company has market cap of $1.84 billion. It operates through North American OTC Healthcare, International OTC Healthcare, and Household Cleaning divisions. It has a 5.55 P/E ratio. The companyÂ’s OTC healthcare products include Chloraseptic sore throat treatments and mouth pain products, Clear Eyes eye care products, Compound W wart removers, Dramamine Non-Drowsy naturals, Efferdent denture cleansers, Luden's throat drops, BC and Goody's analgesic powders, Beano for gas prevention, Debrox for ear wax removal, and Gaviscon for upset stomach remedies.

The stock decreased 3.31% or $1.22 during the last trading session, reaching $35.6. About 340,850 shares traded. Prestige Consumer Healthcare Inc. (NYSE:PBH) has declined 23.36% since December 6, 2017 and is downtrending. It has underperformed by 38.98% the S&P500.

Analysts await Prestige Consumer Healthcare Inc. (NYSE:PBH) to report earnings on February, 7. They expect $0.80 earnings per share, up 14.29 % or $0.10 from last year’s $0.7 per share. PBH’s profit will be $41.39M for 11.13 P/E if the $0.80 EPS becomes a reality. After $0.65 actual earnings per share reported by Prestige Consumer Healthcare Inc. for the previous quarter, Wall Street now forecasts 23.08 % EPS growth.

Manor Road Capital Partners Llc holds 5.69% of its portfolio in Prestige Consumer Healthcare Inc. for 950,000 shares. Aristotle Fund L.P. owns 144,000 shares or 5.59% of their US portfolio. Moreover, Skyline Asset Management Lp has 1.6% invested in the company for 526,900 shares. The Connecticut-based Lapides Asset Management Llc has invested 1.52% in the stock. Aristotle Capital Boston Llc, a Massachusetts-based fund reported 337,663 shares.

More notable recent Prestige Consumer Healthcare Inc. (NYSE:PBH) news were published by: which released: “The Shares Of Prestige Brands Are A Buy – Seeking Alpha” on June 25, 2018, also with their article: “Prestige Brands Holdings, Inc. 2019 Q1 – Results – Earnings Call Slides – Seeking Alpha” published on August 02, 2018, published: “Prestige Brands Holdings (PBH) Presents At William Blair 2018 Growth Stock Conference – Slideshow – Seeking Alpha” on June 13, 2018. More interesting news about Prestige Consumer Healthcare Inc. (NYSE:PBH) were released by: and their article: “Prestige Brands Holdings beats by $0.02, beats on revenue – Seeking Alpha” published on November 01, 2018 as well as‘s news article titled: “Prestige Brands Holdings (PBH) Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: May 10, 2018.

Prestige Consumer Healthcare Inc. (NYSE:PBH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.